APOE and Alzheimer disease: These findings suggest that the isoform-dependent risk (ApoE4 > ApoE3 > ApoE2) to late-onset Alzheimer’s disease may be contributed by the differences in biochemical properties of ApoE isoforms and the subsequent cellular cascades that ApoE regulates.